Delivery Order SPE2DR25D9370-SPE2DR26FKUU2

The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract vehicle awarded on November 13, 2025, that authorizes DLA to procure a comprehensive range of pharmaceuticals, biologics, and medical consumables to support Department of Defense healthcare operations worldwide.

DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical supplier within the military pharmaceutical supply chain, with numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division throughout 2025. The company's extensive product portfolio spans branded and generic prescription medications, vaccines, biologics, specialty pharmaceuticals, and medical consumables, positioning it as a key regional prime vendor under the broader $30.3 billion PPV-G GEN V acquisition strategy. The contract structure with a 30-month base period and three 30-month option periods through December 31, 2036, establishes DMS Pharmaceutical Group as a long-term strategic supplier for recurring pharmaceutical needs across military healthcare facilities globally.